2014
DOI: 10.1016/j.cppeds.2014.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune Hepatitis: A Classic Autoimmune Liver Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 42 publications
1
15
0
2
Order By: Relevance
“…Thus, the upregulation of vimentin, at day 1 pi, might be an indirect effect provoked by E75CV1 infection on surrounding non-infected cells. Coincidently, vimentin and other proteins specifically upregulated at day 1 pi with E75CV1, such as HSPB1, enolase or LCP-1 (Additional file 1), share both their potential role in immune defense and their description as autoantigens in autoimmune disorders [34]. In particular, the role of HSPs as immunogenic molecules able to activate T cells has been long known [35] and several reports have shown that pretreatment with HSPs protects from autoimmune disease [36].…”
Section: Table 6 Analysis Of the Canonical Pathways Corresponding To mentioning
confidence: 99%
“…Thus, the upregulation of vimentin, at day 1 pi, might be an indirect effect provoked by E75CV1 infection on surrounding non-infected cells. Coincidently, vimentin and other proteins specifically upregulated at day 1 pi with E75CV1, such as HSPB1, enolase or LCP-1 (Additional file 1), share both their potential role in immune defense and their description as autoantigens in autoimmune disorders [34]. In particular, the role of HSPs as immunogenic molecules able to activate T cells has been long known [35] and several reports have shown that pretreatment with HSPs protects from autoimmune disease [36].…”
Section: Table 6 Analysis Of the Canonical Pathways Corresponding To mentioning
confidence: 99%
“…When elevation of transaminase occurs in idiosyncratic DILI, mitochondrial dysfunction is already present, which leads to hepatocyte death. In contrast, liver injury due to viral infection or autoimmunity is induced by an immune response to antigens on the hepatocytes . The different pathophysiological causes of liver damage may explain the variable responses to immunosuppression therapy: AIH‐induced ALI/ALF responds well to immunosuppression therapy, while drug‐induced ALI/ALF does not …”
Section: Discussionmentioning
confidence: 99%
“…In contrast, liver injury due to viral infection or autoimmunity is induced by an immune response to antigens on the hepatocytes. [39][40][41][42] The different pathophysiological causes of liver damage may explain the variable responses to immunosuppression therapy: AIHinduced ALI/ALF responds well to immunosuppression therapy, while drug-induced ALI/ALF does not. 6 During the review process, we analyzed diagnostic efficacy of IP-10, SOD2 and CK-18F to predict DILI development using receiver-operator curve analysis.…”
Section: Discussionmentioning
confidence: 99%
“…dIscusIón La HAI es una enfermedad heterogénea con edad de presentación variable que afecta a cualquier raza, y, de no ser tratada, puede progresar de forma frecuente a cirrosis 10 . El sistema de puntaje inicial descrito en 1999 tiene la posibilidad de ser aplicado antes o después del tratamiento inmunosupresor (Ver Tabla 1) 13 .…”
Section: Presentación De Caso Clínicounclassified
“…A pesar de no conocerse la causa específica de la enfermedad, se considera que se desarrolla en personas con predisposición genética que se exponen a algún agente desencadenante como bacterias, virus, hongos u otras partículas externas al organismo 9,10 ; la caracterización del cuadro clínico es de amplio rango presentándose desde formas asintomáticas solo detectables por elevaciones moderadas de las aminotransferasas hasta casos de hepatitis severa fulminante 1, 11,12 . De esta forma, la mayoría de los pacientes son asintomáticos o presentan formas leves de la enfermedad, siendo los síntomas generales inespecíficos como astenia, fatiga y debilidad un motivo de consulta frecuente.…”
Section: Introductionunclassified